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Background. In the pathogenesis of atherosclerosis, a central role is represented by endothelial inflammation with influx of
chemokine-mediated leukocytes in the vascular wall. Aim of this study was to analyze the effect of different shear stresses
on endothelial gene expression and compute gene network involved in atherosclerotic disease, in particular to homeostasis,
inflammatory cell migration, and apoptotic processes. Methods. HUVECs were subjected to shear stress of 1, 5, and 10 dyne/cm2
in a Flow Bioreactor for 24 hours to compare gene expression modulation. Total RNA was analyzed by Affymetrix technology and
the expression of two specific genes (CXCR4 and ICAM-1) was validated by RT-PCR. To highlight possible regulations between
genes and as further validation, a bioinformatics analysis was performed. Results. At low shear stress (1 dyne/cm2) we observed
the following: (a) strong upregulation of CXCR4; (b) mild upregulation of Caspase-8; (c) mild downregulation of ICAM-1; (d)
marked downexpression of TNFAIP3. Bioinformatics analysis showed the presence of network composed by 59 new interactors
(14 transcription factors and 45 microRNAs) appearing strongly related to shear stress. Conclusions. The significant modulation
of these genes at low shear stress and their close relationships through transcription factors and microRNAs suggest that all may
promote an initial inflamed endothelial cell phenotype, favoring the atherosclerotic disease.
1. Background
The development of atherosclerosis is commonly associated
with high levels of lipids in blood able to generate the
development of sclerotic plaques. New knowledge from basic
and experimental science has demonstrated the role for
inflammatory pathway in early events of disease pathogen-
esis. Different in vivo animal models of atherosclerosis show
signs of inflammation, both at local than at systemic levels,
associated with lipid accumulation in the artery wall. For
example, leukocytes, important mediators of host defenses
and inflammation, localize in earliest lesions in animal
models and in humans as well [1].Themolecularmechanisms
involved in lymphocytes recruitment by activated endothelial
cells at atherosclerotic lesion formation sites are similar to
those reported for neutrophils and monocytes [1, 2]. The
different steps of atherogenic leukocyte recruitment such
as rolling, adhesion, and transmigration are controlled by
functionally specialized chemokines [3, 4]. Whereas soluble
chemokines were first described to induce directed chemo-
taxis of leukocytes, chemokines trigger the integrin-mediated
arrest of rolling leukocytes [5, 6]. Chemokine/chemokine
receptor network is essential for direction of leukocytemigra-
tion in homeostatic and inflammatory conditions. Numerous
reports described the important role of chemokines and of
their receptors in the regulation of leukocyte recruitment
during atherosclerosis [7]. Chemokine (C-X-Cmotif) Recep-
tor 4 (CXCR4) signaling has been reported to modulate cell
chemotaxis, survival [1, 8], and apoptosis [9–11]. Through
this receptor the Macrophage Migration Inhibitory Factor
Hindawi
BioMed Research International
Volume 2018, Article ID 5359830, 12 pages
https://doi.org/10.1155/2018/5359830
2 BioMed Research International
(MIF), able to regulate inflammatory cell (T cells, monocytes)
recruitment to lesion area [12, 13], expresses its proathero-
genic action.
Involved inmonocyte adhesion is also Intercellular Adhe-
sion Molecule 1 (ICAM-1). Upon cytokine stimulation with
Tumor Necrosis Factor alpha (TNF-alpha) [14], Angiotensin
II, and Oxidized Low Density Lipoprotein (ox-LDL) [15],
ICAM-1 expression increases in wall vessel cells [16, 17] pro-
ducing proinflammatory effects with leukocyte recruitment.
Although the pathobiology of atherosclerosis is a complex
biological multifactorial process, blood flow-induced shear
stress has emerged as essential feature of atherogenesis. This
fluid drag force, acting on vessel wall, is mechanotrans-
duced into biochemical signals, resulting in vascular behavior
changes. Maintenance of physiologic, laminar shear stress
is known to be crucial for normal vascular functioning,
which includes regulation of vascular caliber, inhibition of
proliferation, thrombosis, and inflammation of the vessel
wall. Nonlaminar flow promotes changes in endothelial gene
expression, cytoskeletal arrangement, leukocyte adhesion,
and vasoreactive, oxidative, and inflammatory states of artery
[5, 18, 19]. Disturbed shear stress also influences site selec-
tivity of atherosclerotic plaque formation and its associated
vessel wall remodeling, which can affect plaque vulnerability
and stent restenosis. Shear stress is critically important in
regulating atheroprotective normal physiology as well as
pathobiology and dysfunction of vessel wall through complex
molecular mechanisms that promote atherogenesis [20].
The aim of this work is to analyze the effect of different
shear stress levels in vitro on endothelial gene expression
using a laminar flow bioreactor [21]. Thanks to microar-
ray analysis, the possible involvement in early phases of
atherosclerotic disease of genes significantly regulated and
linked to inflammatory and apoptotic process have been
observed. In particular, CXCR4, ICAM-1, Tumor Necrosis
Factor Alpha-Induced Protein 3 (TNFAIP3), and Caspase-8
(CASP8) genes that present a role in atherosclerosis devel-
opment at different level and with different functions were
considered. With the support of bioinformatics analysis it
is possible to highlight existing relationships between genes
under investigation generating a potential regulation system
network.
2. Methods
2.1. Endothelial Cell Culture. PrimaryHumanUmbilical Vein
Endothelial Cells (HUVECs) were isolated from human
cords. Fresh human umbilical cords were recovered from
healthy females at the Obstetrics and Gynecology Unit of
the AziendaOspedaliera Universitaria Pisana, after obtaining
written informed consent for use of these samples in research
approved by the Local Ethics Committee of Area Vasta Nord
Ovest. The umbilical cords were stored in PBS at 4∘C, sent
to our laboratory within 1 hour of delivery, and treated
anonymously conforming with the principles outlined in
the Declaration of Helsinki. Umbilical vein was cannulated,
washed with Phosphate Buffered Saline (PBS) solution, and
filled with 3 mg/ml collagenase IV solution in PBS. After
Figure 1: Assembled laminar flow bioreactor (LFB). Bioreactor is
composed by amixing chamber filled with a complete culturemedia
with 5% of Dextran, a cell culture chamber, and a peristaltic pump.
All the components were connected in a closed loop and put in an
incubator to preserve temperature (37∘C) and CO2 concentration in
air (5%).
20 min in incubator, it was washed again with Endothelial
Cell Growth Medium (ECGM) (Promocell, Heidelberg, Ger-
many) to block collagenase action and, after centrifugation
(900 rpm, 5 min), pellet was recovered with fresh complete
media and seeded in gelatin 1% pretreated flask for cell
adhesion. Every 2 days media culture was changed, until the
confluence.
2.2. Bioreactor. The bioreactor system [21, 22] (Figure 1) is
composed by a mixing chamber, filled with 12 ml of complete
culture media supplemented with 5% of Dextran (Sigma-
Aldrich, St. Louis, MO, USA), a cell culture chamber, and a
peristaltic pump (ISMATEC, Wertheim, Germany). All the
components were connected in a closed loop and assembled
system was put in incubator.
In order to obtain a central region with a well-defined
and uniform wall shear stress, active cell culture chamber
(70x20x2 mm3) shape was designed by accurate modeling
analysis performed with finite element software for simula-
tion of fluid dynamic flow [21].
The chamber is fabricated in polydimethylsiloxane
(PDMS, Sylgard 184) (Dow Corning, Midland, MI, USA), a
biocompatible silicone polymer, through mill-molding.
2.3. Bioreactor Experimentation. For experiments, HUVECs
between 2nd and 5th passage were used. When at conflu-
ence, cells were treated with 0.5% Trypsin (Lonza, Basel,
Switzerland). Once detached from flask, endothelial cells
were centrifuged at 900 rpm for 5 min. Pellet was resus-
pended in fresh media; cells were counted and seeded (15000
cells/cm2) on fibronectin 3 𝜇g/cm2 pretreated Thermanox
slides (dimensions 2 x 6 cm2) (NUNC, Rochester, NY, USA).
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When HUVECs covered surface slide, experiments with
bioreactor started. The system was set in order to furnish
different flow conditions, corresponding to shear stress values
of 1, 5, and 10 dyne/cm2. Every experiment had duration
of 24 hours; at the end, slides were recovered and cell
images acquired under microscope. Then, endothelial cells
were trypsinized with 200 𝜇l/slide. Once cells were detached,
1 ml of medium was added to block trypsin action and
50 𝜇l of suspension was recovered, before centrifugation,
to perform CellTiter-Blue Cell Viability Assay (Promega,
Madison, USA). This assay is useful for monitoring cell
viability through the ability of living cells to convert a dye
(resazurin) into a fluorescent end product (resorufin, 579ex
/584em).
Finally, residual cell medium was centrifuged and the
pelletwas resuspended in 50𝜇l of RNA later solution (Qiagen,
Hilden, Germany) and frozen at -20∘C to prevent RNA
degradation until the genetic analysis.
2.4. Total RNA Extraction. Total RNA has been extracted
from HUVECs using RNeasyMicro Kit QIAGEN for small
amounts of human cells (≤ 5 x 105cells). Briefly, cell pellets
were first lysed and homogenized in a highly denatur-
ing guanidine-isothiocyanate-containing buffer and ethanol,
which immediately inactivates RNases to ensure isolation of
intact RNA.The lysatewas passed through aRNeasyMinElute
spin column, where total RNA binds to the membrane and
contaminants were washed away. Traces of DNA that may
copurify are removed by a DNase treatment.
The RNA quality control was performed with the Agilent
BioAnalyzer system (Agilent Technologies, Santa Clara, CA,
USA) that separated and subsequently detected RNA samples
via laser induced fluorescence detection.
2.5. Microarray Analysis by Affymetrix Technology. 100 ng
of total RNA from each experimental set has been ampli-
fied resulting in unlabeled cDNA. An in vitro transcrip-
tion reaction was performed in presence of biotin-labeled
ribonucleotides mixture to produce biotinylated cRNA
from the cDNA template. Biotinylated cRNA molecules
were hybridized to their complementary sequences on
the GeneChip surface. For each experimental condition, 2
microarrays (HG-U133-Plus 2.0,Affymetrix, SantaClara, CA,
USA) have been used; every array allows measuring the
expression level of over 47,000 human transcripts, repre-
senting 38,573 gene clusters in the UniGene database plus
841 anonymous full-length transcripts, and a number of
anonymous partial sequences of cDNA.Thefluorescence data
were processed using MicroArray Suite software version 5.0
(Affymetrix). Data from the gene microarray experiments
were preprocessed using the Robust Multiarray Average
(RMA) algorithms making adjustments for systematic errors
introduced by differences in procedures and dye intensity by
collaboration of COGENTECH (Consortium for Genomic
Technologies, Milan, Italy). Microarray data have been sub-
mitted to the Gene Expression Omnibus (GEO) under
accession n. GSE45225.
2.6. Quantitative Real-Time PCR of CXCR4 and ICAM-1. For
Real-Time Polymerase Chain Reaction (RT-PCR), the reverse
transcription of total RNA (500 ng) was performed using the
Transcriptor First strand cDNA synthesis kit (Roche Applied
Science, Indianapolis, IN, USA).
Every cDNA solution (2 𝜇l) was mixed with MgCl2
(3 mM), primers (0.3 𝜇M) and Hybridization Probes (0.15
𝜇M), designed ad hoc by TIBMOLBIOL (Roche), and with
LightCyclerFastStart DNA Master Mix by Roche (10X). The
cycling protocol consisted of denaturation step at 95∘C for 10
s, annealing step at 58∘C for 10 s and extension step at 72∘C
for 10 s.This protocol was repeated for 45 times. Fluorescence
was detected at 640 nm and measured at the end of each
extension step. The LightCycler software 4.05 calculated the
Crossing point, (Cp), where the samples fluorescence curve
turns sharply upward. This turning point corresponds to the
first maximum of the second derivative of the curve. For final
quantification of samples, an external calibration curve was
obtained using specific amplicon with known concentration.
2.7. Preparation of Standard Curve. For absolute quantifica-
tion of CXCR4 and ICAM-1 gene expressions, we prepared
standard curves amplifying a fragment of CXCR4 or ICAM-1
transcript coming from a sample of cDNA with conventional
PCR. The resulting fragments were purified by the QIAquick
PCR Purification kit protocol (QIAgen). CXCR4 (46.1 ng/l)
and ICAM-1 (25.5 ng/l) products were measured at 260 nm.
Sevenfold serial dilutions of quantified ICAM-1 and CXCR4
standard amplicons were used for standard curve preparation
(7 points with concentration range from 10−4 to 10−10 ng/l).
2.8. Statistical Analysis. After quantile normalization and
filtering with a false discovery rate below 20% (FDR < 0.2),
6807 genes of 40508 analyzed were selected and clustered
by Euclidean distance measure. Genes were sorted for dif-
ferential expression based on one-way ANOVA andDifferent
ExpressedGenes (DEG)were identified as those genes having
adjusted p values < 0.05 with Fold Change (FC) ≥ 2 fold in
modulus.
2.9. Bioinformatics Analysis. In order to further support wet
lab results and to obtain awider understanding of the possible
regulations surrounding genes in HUVECs under low shear
stress, and their role in the early phases of atherosclerosis, a
bioinformatics approach was performed. Regulators include
bothmicroRNA and Transcription Factors (TF) whose role is
central in posttranscriptional and transcriptional regulation
and whose contribution may better uncover the dynamics
of the regulatory interaction that take place in the network
comprising the already identified genes.
For the network enhancing process, we used ReNE
(Regulatory Network Enhancer), a Cytoscape 3.x plugin we
developed to automatically enrich a gene-based regulatory
network by adding transcriptional, posttranscriptional, and
translational data [23]. During the enhancing process, ReNE
automatically retrieves regulatory information frommultiple
public repositories (i.e., miRIAD, TargetMine, miRanda,
NCBI, UniProt, TargetHUB, PicTar, miRTarBase, TargetScan,
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Figure 2: HUVECs under shear stress conditions. Picture of HUVECs subjected at 0 (a), 1 (b), 5 (c), and 10 dyne/cm2 (d) after 24 hours of
stimulus (scale bar equal to 100 𝜇m).
and miRBase) and also provides a set of utilities in order
to filter out the large amount of false positive predictions
(usually stored in public repositories) for guaranteeing more
reliable data.
3. Results
3.1. Flow Dependence of Cell Reorganization and Viability.
Endothelial cells were photographed in order to analyze cell
shape and behavior at different shear stress levels. One of the
first results was the detection of flow-induced modifications
on cell morphology, characterized by cytoskeletal reorganiza-
tion, with prevalent cobblestone shape and initial elongated
structure (Figures 2(b), 2(c), 2(d)) with respect to control
(Figure 2(a)).
Furthermore, cell viability presented a statistical increase
in the case of 1 dyne/cm2 with respect to 5 and 10 dyne/cm2,
indicating that lowest shear stress conferred proliferative
behavior to endothelial cells (Figure 3).
This last result highlights a significant modulation by
shear stress of cell activity, in terms ofmetabolic/proliferating
profile but also in genetic modulation of biological mediators
of our interest.
3.2. Microarray Results. Microarray data were published
on Gene Expression Omnibus (GEO) (access number
GSE45225). Globally, 3000 ID probes were found to be differ-
entially expressed in our experimental conditions. HUVECs
exposed to different shear stress values were initially com-
pared with those that had been maintained under static con-
ditions to verify howmany gene expressions weremodulated.
As shown in Table 1, the used low shear stress regulated
463 ID probes with respect to static condition, while middle
and high shear stress expressed 1008 and 921 different genes,
respectively, compared to no flow state.
A comparison between flows may give a more accurate
picture of gene expression modulation in physiological or
pathological states. Low shear stress, compared tomiddle and
high flow, regulated 142 and 397 different genes, respectively.
Among 397 genes of 1 versus 10 dyne/cm2 stress, 206 (52%)
were up- and 191 (48%) were downregulated; in 1 versus 5
dyne/cm2 comparison 57 (40%) were up- and 85 (60%) were
downregulated.
In the comparison between low and high shear stress,
we focused on genes that showed the highest up- and
downregulation (selection criteria were p<0.05 and FC>2).
Microarray analysis (Table 2) highlighted a strong upreg-
ulation ofCXCR4 at low (1 dyne/cm2) compared to high shear
BioMed Research International 5
Table 1: Number of differentially expressed genes between conditions.
Comparison Factor considered Selection criterion Number of DEG
0 vs 1 Flow effect p<0.05 & |FC| >2 463
0 vs 5 Flow effect p<0.05 & |FC| >2 1008
0 vs 10 Flow effect p<0.05 & |FC| >2 921
1 vs 5 Flow effect p<0.05 & |FC| >2 142
1 vs 10 Flow effect p<0.05 & |FC| >2 397
Table 2: Fold variations of genes under investigation with microarray technique.
Probeset ID Gene Fold variation 1 vs 5 Fold variation 1 vs 10
209201 x at CXCR4 2.76 5.42
217028 at CXCR4 2.78 5.54
211919 s at CXCR4 2.15 4.53
213373 s at CASP-8 - 2.13
202643 s at TNFAIP3 -2.09 -3.28
202644 s at TNFAIP3 -2.71 -4.19
202637 s at ICAM-1 -2.10 -3.88
202638 s at ICAM-1 -2.05 -3.33
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Figure 3: Cell viability of HUVECs after shear stress treatment.
(ANOVA statistical analysis p<0,05 for: 1 versus 5; 1 versus 10).
stress (4.53-5.54 fold variation) and significant at intermedi-
ate level (2.15-2.78 fold variation) in inversely proportional
shear-dependent manner. Caspase-8 gene was significantly
upregulated only at low shear stress with respect to 10
dyne/cm2 (2.13 fold variation). Conversely, a marked down-
regulation of TNFAIP3 gene (-4.19- and -3.28-fold variation)
was observed. A mild reduction in gene expression (-3.33-
and -3.88-fold variation) was observed also for ICAM-1 when
1 dyne/cm2 was compared to 10 dyne/cm2. In general, low
shear stress seems to represent a key factor in gene expression
modulation of endothelial response to fluid dynamical forces.
3.3. Quantitative Real-Time PCR Results. Microarray results
gave a global vision about the effects of fluid mechanical
stimulation on endothelial cell culture. Focusing on the role
of chemokines in early stages of atherosclerosis development,
gene expressions of CXCR4 and ICAM-1 mediators were
also analyzed. Results from RT-PCR confirmed the trend
observed for these genes in microarray analysis. ICAM-1
mRNA levels increased from 1 to 10 dyne/cm2 (Figure 4(a))
while CXCR4 gene expression, high at 1 dyne/cm2, decreased
when compared to 5 and 10 dyne/cm2 experiments (Fig-
ure 4(b)). Both ICAM-1 and CXCR4 mRNA concentrations
are very low in static condition.
3.4. Bioinformatics Analysis. We used ReNE to enhance and
better understand regulatory relations that take place among
the previously identified genes. In order to copewith the large
amount of false positive microRNA predicted targets, usually
present in public repositories, we only collected microRNA
targets confirmed by miRTarBase [24]. MiRTarBase collects,
in fact, only experimentally validatedmicroRNA-target inter-
actions, which resulted in a smaller and more reliable set of
microRNAs. Transcription factors have been collected from
TargetMine [25].
The enhanced network is depicted in Figure 5 and the list
of enhanced entities (transcription factors and microRNAs)
is synoptically reported in Table 3.
We validated through literature the whole set of discov-
ered regulatory entities, to estimate both their role under
shear stress conditions and the overall reliability of the
resulting enhanced network. Results confirmed the expected
reliability of the enhanced network, given an overall vali-
dation of 88,3% (40 out 46 microRNAs and 13 out of 14
transcription factors appear directly involved in shear stress
or in shear stress induced inflammation).
Overall, the proposed enhanced network confirms the
role of CXCR4, TNFAIP3, and CASP8 plus X-box Binding
Protein 1 (XBP1) in shear stress, further enlarging the set
of regulations and highlighting the presence of common
regulatory motif composed by TFs and microRNAs, already
recognized in shear stress, that possibly finely tune the
pathway behavior.
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Figure 4: RT-PCR of ICAM-1 (a) and CXCR4 (b) genes in the different shear stress conditions.
Figure 5: Schematic representation of the enhanced network. (i) Squares represent the genes previously identified in wet lab assessment, (ii)
diamonds represent microRNAs, and (iii) hexagons represent transcription factors. The node stroke represents the role of each regulator as
follows: angiogenesis (red), apoptosis (dark green), atherogenesis (light green), Inflammatory response (orange), NO synthesis and response
(pink), senescence (blue), shear stress regulation (purple), and previously identified genes (light gray).
BioMed Research International 7
Table 3: List of microRNA and transcription factors added to the regulatory network after the enhancing process. Node represents the
regulator’s name, type describes if the regulator is a transcription factor or a microRNA, PMID is the PubMed ID of the reference paper, and
Function contains the overall regulatory function.
Node Type PMID Function
HSA-MIR-155 External Mirna 23512606 Angiogenesis
HSA-MIR-18A External Mirna 21171923 Angiogenesis
HSA-MIR-18B External Mirna 21171923 Angiogenesis
HSA-MIR-20B External Mirna 24158362 Angiogenesis
HSA-MIR-22 External Mirna 23512606 Angiogenesis
HSA-MIR-221 External Mirna 23512606 Angiogenesis
HSA-MIR-222 External Mirna 23512606 Angiogenesis
HSA-LET-7A-1 External Mirna 21171923 Apoptosis
HSA-LET-7A-2 External Mirna 21171923 Apoptosis
HSA-LET-7A-3 External Mirna 21171923 Apoptosis
HSA-LET-7G External Mirna 21171923 Apoptosis
HSA-MIR-17 External Mirna 21171923 Apoptosis
HSA-MIR-20A External Mirna 21171923 Apoptosis
HSA-MIR-29B-1 External Mirna 21171923 Apoptosis
HSA-MIR-29B-2 External Mirna 21171923 Apoptosis
HSA-MIR-488 External Mirna 21710544 Apoptosis
HSA-MIR-103A-1 External Mirna 22267480 Atherogenesis
HSA-MIR-103A-2 External Mirna 22267480 Atherogenesis
HSA-MIR-24-1 External Mirna 23729638 Atherogenesis
HSA-MIR-24-2 External Mirna 23729638 Atherogenesis
HSA-MIR-26A-1 External Mirna 22267480 Atherogenesis
HSA-MIR-26A-2 External Mirna 22267480 Atherogenesis
HSA-MIR-31 External Mirna 23729638 Atherogenesis
HSA-MIR-146A External Mirna 21171923 Inflammatory response
HSA-MIR-193B External Mirna 23729638 Inflammatory response
HSA-MIR-206 External Mirna 23381794 Inflammatory response
HSA-MIR-208A External Mirna 23797034 Inflammatory response
HSA-MIR-224 External Mirna 22178270 Inflammatory response
HSA-MIR-302C External Mirna 21490602 Inflammatory response
HSA-MIR-34A External Mirna 21171923 Inflammatory response
HSA-MIR-34C External Mirna 26779287 Inflammatory response
HSA-MIR-378A External Mirna 25104350 Inflammatory response
HSA-MIR-9-1 External Mirna 23797034 Inflammatory response
HSA-MIR-9-2 External Mirna 23797034 Inflammatory response
HSA-MIR-9-3 External Mirna 23797034 Inflammatory response
HSA-MIR-98 External Mirna 25623956 Inflammatory response
HSA-MIR-19A External Mirna 22047531 NO synthesis and response
HSA-MIR-200B External Mirna 23975169 NO synthesis and response
HSA-MIR-21 External Mirna 22047531 NO synthesis and response
HSA-MIR-127 External Mirna 24282530 Senescence
HSA-MIR-34B External Mirna 20424141 Senescence
HSA-MIR-145 External Mirna 23512606 Shear stress regulation
HSA-MIR-19B-1 External Mirna 25012134 Shear stress regulation
HSA-MIR-19B-2 External Mirna 25012134 Shear stress regulation
AR Transcription Factor 26097556 Inflammatory response
CREB1 Transcription Factor 25883219 Inflammatory response
ESR1 Transcription Factor 26808832 Inflammatory response
FOXA1 Transcription Factor 24801505 Inflammatory response
FOXP3 Transcription Factor 21873519 Inflammatory response
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Table 3: Continued.
Node Type PMID Function
IRF1 Transcription Factor 23934855 Inflammatory response
IRF2 Transcription Factor 2475256 Inflammatory response
YBX1 Transcription Factor 23872051 Inflammatory response
ETS1 Transcription Factor 18636553 Shear stress regulation
GATA1 Transcription Factor 15231498 Shear stress regulation
GATA2 Transcription Factor 15231498 Shear stress regulation
GATA3 Transcription Factor 15231498 Shear stress regulation
MYC Transcription Factor 9598824 Shear stress regulation
PAX5 Transcription Factor 19616560 Shear stress regulation
4. Discussion
In this work, our attention was focused on first modifications
occurring to endothelial cell gene profile, able to induce
the development of an atherosclerotic lesion. The analysis of
results shows a peculiar pattern of gene modulation linked
to inflammation and we highlight a possible gene network
involved in this pathological process.
The presence of low shear or nonlaminar flow is able to
induce changes in gene expression profile that predispose
endothelium to the initiation and development of atheroscle-
rotic lesions [26, 27].
We decided to submit HUVECs at a well-defined range of
shear stress values (0, 1, 5, and 10 dyne/cm2) to cover a wide
spectrumof conditions, according to flow ranges employed in
themajority of publications [28–31]. Physiologic fluid flows in
the ranges of about 1-50 dyne/cm2 [32, 33] are found in vivo in
the majority of blood vessels and its disturbance can produce
pathogenic states such as thrombosis and atherosclerosis.
It has verified that regions of arterial circulation prone
to develop atherosclerosis are characterized by “disturbed,”
oscillatory flow with low levels of shear stress (mean time-
averaged shear stress ≤ 1 dyne/cm2) [34]. The range of flow
we chose let us analyze physiological shear stress (5 and 10
dyne/cm2) with respect to a proatherogenic shear rate (1
dyne/cm2).
Obtained results show that shear stress modulates cell
structure in terms of cytoskeletal reorganization with a
cobblestone architecture at all shear stress values and with a
smooth elongation at 10 dyne/cm2. This behavior is similar
to that observed by Sakamoto [35], where only cell exposed
to high shear stress showed a tendency to align parallel to
the direction of flow. Our results are similar to those from
literature also in terms of cell viability: a significant increase
of cell metabolic activity was obtained at low shear stress, as
previously observed by Conway et al. [31].
Furthermore, the comparison of different shear rates on
a uniform culture of human endothelial cells by microarray
analysis highlights the earliest potential modulator of the
disease process.
In our genetic study, Affymetrix analysis showed a regu-
lation of various genes, in particular linked to inflammation
and apoptosis, such as CXCR4, ICAM-1, Caspase-8, and
TNFAIP3 genes. These experiments highlighted a strong
upregulation of CXCR4 and a >2 fold increase for Caspase-8;
on the other hand, remarkable downregulation of TNFAIP3
and, less in amplitude, of ICAM-1 was evidenced. Further-
more, the expression values of two genes, CXCR4, for its
highest overexpression, and ICAM-1, known to be involved
in the atherosclerotic process, were confirmed with RT-PCR.
The overexpression of CXCR4 seems to indicate an active
state of endothelial cells subject to a low shear stress, a
first signal of “reaction” to the atheroprone waveform of
flow in the bioreactor. CXCR4, as chemokine receptor, is
involved in the MIF action. This is widely expressed in
macrophages and endothelial cells of atherosclerotic plaques
and induces integrin-independent arrest and transmigration
of monocytes and T cells. MIF contributes, in this way,
to lesion progression and plaque inflammation trough the
interaction with CXCR4 [12, 13, 36].
The MIF involvement in atherosclerotic plaque pro-
gression was confirmed using MIF−/−/LDL-R−/−mice on an
atherogenic diet for 12 and 26 weeks [37]. Interestingly,
in vitro adhesion assays revealed that monocyte adhesion
on ox-LDL-treated human aortic endothelial cells depends
almost completely on endothelial MIF and stimulation of
aortic endothelial cells with MIF for 2 h induced monocyte
adhesion under flow conditions, providing preliminary hints
to a chemokine-like function ofMIF in leukocyte recruitment
[38].
Regarding ICAM-1 gene levels, our finding shows a
decrease of ICAM-1 gene expression at low shear stress, dif-
fering from previously published data [28]. These conflicting
results can be explained both by the absence of an inflamma-
tory stimuli [14, 15] and by its role in elaboration of “mature”
atherosclerotic lesions [39]. On the other hand, Conway et
al. [31], comparing the effects of reversing shear stress (time-
average: 1 dyne/cm2, max: +11 dyne/cm2, min: -11 dyne/cm2, 1
Hz), arterial steady shear stress (15 dyne/cm2), and low steady
shear stress (1 dyne/cm2) on surface expression of ICAM-
1, cell proliferation, and monocyte adhesiveness, verified
that only reversing shear stress exposure induced monocyte
adhesion. ICAM-1 expression was also lower at 1 dyne/cm2
with respect to 15 dyne/cm2, confirming our results. Laminar
flow produced a significant time-dependent increase in the
surface expression of ICAM-1 on endothelial cells, while
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turbulent flow did not affect its surface expression [40, 41]. A
direct link between shear stress and ICAM-1 gene expression,
through the identification of a Shear Stress Response Element
(SSRE) in the promoter region for the ICAM-1 gene, has been
established by Resnick [42].
Considering the literature, also Caspase-8 and TNFAIP3,
the other two genes most modulated in our experiments, can
assume an interesting role.
Caspase-8 is an initiator of the extrinsic pathway of apop-
tosis. Scharner [43] demonstrated the strictly link between
Caspase-8 and CXCR4. Aging with a blocker of apoptotic
agent, a downregulation of CXRC4 expression on EPCs in
vitro was observed. On the other hand, the role of altered
shear stress, like low flow, as a regulator of cell apoptosis has
recently been demonstrated by Li and Xu [44]. In endothelial
cells, disturbed flow stress resulted in a sustained activation
of beta-1 integrin system linked to the X-box Binding Protein
1 (XBP1), which functions as a key signal transducer resulting
in increase of caspase activation in endothelial cells [45].
Referring to the literature, in our work a possible correlation
between CXCR4 and Caspase-8 can be shown, furnishing an
interesting new research starting point
Regarding TNFAIP3, in our experimental model, low
flow downexpressed the gene, which has normally a protec-
tive function against apoptosis and inflammation through
the blockade of the transcription factor, Nuclear Factor
kappa-light-chain-enhancer of activatedB cells (NF-kB) [46].
In cultures derived from primary cells, various investiga-
tors have found that overexpression of TNFAIP3 protects
cells from cycloheximide/TNF–, ceramide/TNF–, and IL-
1–mediated apoptosis [47–49]. This link between apoptosis
and TNFAIP3 was also demonstrated by Daniel et al. [50].
TNFAIP3 also blunts natural killer cell-mediated EC apop-
tosis by inhibiting Caspase-8 activation. These data show the
cytoprotective effect of TNFAIP3 in ECs. In our experiments
the downregulation of TNFAIP3 may explain the correlated
upregulation of Caspase-8 gene, favoring an inflammatory
and proatherogenic cell condition.
The wet lab results were further exploited resorting these
by bioinformatics analysis: the set of previous identified genes
(i.e., CXCR4, TNFAIP3, and CASP8 plus XBP1) was enriched
with the set of its upstream regulators (i.e., microRNAs
and transcription factors) (Figure 5). This approach allowed
deeper insight about the regulatory gene dynamics under low
shear stress conditions.
The enhancing process added to the network 59 new
interactors (14 transcription factors and 45 microRNAs)
(Table 3), each of them has been validated in literature
in order to evaluate its role and to measure the overall
reliability of the enhanced network. Interestingly, all the
newly introduced regulators, except one, appear strongly
related to the shear stress phenomenon.
The 14 transcription factors appear evenly distributed
between inflammatory response (8 out of 14: IRF2, FOXP3,
YBX1, IRF1, FOXA1, CREB1, AR, and ESR1) and shear stress
regulation (6 out of 14: MYC, GATA1, GATA2, GATA3, ETS1,
and PAX5). In particular, ETS1, GATA2, and FOXP3 act as
hubs by targeting all the previously identified genes and ESR1,
MYC, and ETS1 are, in turn, coregulated by large separated
groups of microRNAs each.
The 44 validated microRNAs are distributed among
multiple classes reported as commonly involved in shear
stress phenomenon: 13 microRNAs are involved in inflam-
matory response, 9 in apoptosis, 7 in both angiogenesis and
atherogenesis, 3 in bothNO synthesis and response and shear
stress regulation, and finally, 2 in senescence.
Three large heterogeneous separated groups of microR-
NAs appear to act in concert to respectively regulate:
ETS1 (hsa-mir-9-1, hsa-mir-9-2, hsa-mir-9-3, hsa-mir-155,
hsa-mir-208a, hsa-mir-200b), ESR1 (hsa-mir-18a, hsa-mir-
18b, hsa-mir-19a, hsa-mir-19b-1, hsa-mir-19b-2, hsa-mir-206,
hsa-mir-20b, hsa-mir-22, hsa-mir-221, hsa-mir-222, hsa-mir-
29b-1, hsa-mir-29b-2, hsa-mir-302c), and MYC (hsa-let-7g,
hsa-mir-145, hsa-mir-17, hsa-mir-20a, hsa-mir-24-1, hsa-mir-
24-2, hsa-mir-26a-1, hsa-mir-26a-2, hsa-mir-34a, hsa-mir-
34c, hsa-mir-378a).
7 microRNAs (hsa-let-7a-1, hsa-let-7a-2, hsa-let-7a-3,
hsa-mir-193b, hsa-mir-21, hsa-mir-31, hsa-mir-34b) act as
regulatory bridges among highly connected regulatory clus-
ters by regulating couple of targets each (transcription factors
and genes).
The only unvalidated element is hsa-mir-4476; neverthe-
less such microRNA has been recently discovered and no
clues about its role are actually available in literature. Giving
the overall reliability of the rest of the enhanced network, the
lack of validation of hsa-mir-4476 makes it a good candidate
for further studies to elucidate its possible involvement in
shear stress.
Furthermore, hsa-mir-4476 is coexpressed by PAX5 and
appears participating in incoherent feed-forward loop reg-
ulatory motif [51]. Such motif acts as a pulse generator and
response accelerator: PAX5 activates XBP1, but also represses
XBP1 by the repression of FOXA1 mediated by hsa-mir-
4476. As a result, when a signal causes PAX5 to assume
its active conformation, XBP1 is rapidly produced. However,
after some time, hsa-mir-4476 levels accumulate to reach the
repression threshold for the XBP1 promoter. As a result, XBP1
production decreases and its concentration drops, resulting
in pulse-like dynamics.
Integrating our data with the state of the art related
to genes under investigation, a potential relation between
CXCR4, Caspase-8, and TNFAIP3 in the development of
the early phases of atherosclerotic disease can be shown
(Figure 6).
In fact, endothelial chemokine receptor CXCR4 activa-
tion at low shear stress (Figure 6(b)) can play a role in
the development of atherosclerosis acting as an important
mediator of the endothelial response to damage through
interaction with MIF.
The concomitant overexpression of Caspase-8, involved
in early phase of apoptotic process, seems closely related to
upregulation of CXCR4 and the downregulation of TNFAIP3
suggest that all these gene modulations can synergistically
promote an initial inflamed cell phenotype at low flow with a
cascade of events that come ahead the endothelial activation
through adhesion molecules expression.
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Figure 6: Representation of relations between CXCR4, TNFAIP3, and Caspase-8 in HUVECs under physiological and low shear stress. At
physiological level (a), shear stress is able to downregulate CXCR4, limiting its role in XBP-1 stimulation with reduction of apoptotic activity
of Caspase-8; in parallel, there is low interaction with MIF, reducing monocyte adhesion and trans-migration in vascular wall. TNFAIP3
is highly expressed and inhibits Caspase-8. This behavior changes when endothelial cells are subjected to low shear stress (b): CXCR4 is
overexpressed, promoting its interaction with MIF and consequent increased monocyte adhesion. Furthermore, it stimulates XBP-1, with
augmented apoptotic activity not counteracted by TNFAIP3, which is downregulated.
ICAM-1 downregulation, instead, can be justified by its
limited role in the very early stages of disease, which become
more important in following phases of atherosclerosis [50,
52].
5. Conclusions
Atherosclerotic process is a pathological event where several
inputs participate to create a network with several players. In
particular, our findings may shed light on specific patterns:
the role of specific mediators of chemokine, caspase, and
inflammatory systems in situations of low shear stress that
might be relevant in the initial phases of atherosclerotic
process and for fundamental regulatory action of laminar
shear stress in preservation of endothelial cell integrity and
survival.
Although our work presents some limitations, like RT-
PCR gene analysis focused only on CXCR4 and ICAM-
1 and no experiments focused on the possible cause-effect
relationship of this hypothesis, it highlights that the con-
comitant modulation of CXCR4, Caspase-8, ICAM-1, and
TNFAIP3 at low shear stress may predispose endothelium to
a preinflamed phase.
At the same time, the emerging findings together with an
integrated approach by theway of bioinformatics tools, which
has enriched the network of specific genes, transcription
factors, and microRNAs, improve knowledge about compre-
hension of chemokine role in early stages of patient plaque
development focalizing a chemokine hypothesis-driven to be
analyzed with further experiments.
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